Michael Kenison
Corporate Officer/Principal presso PROTO LABS, INC.
Patrimonio netto: 692 210 $ in data 31/05/2024
Profilo
Michael R.
Kenison is currently the Vice President & General Manager-Americas at Proto Labs, Inc. He previously worked as the Vice President-Manufacturing at Cardiac Science, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PROTO LABS, INC.
0.09% | 20/05/2024 | 22 351 ( 0.09% ) | 692 210 $ | 31/05/2024 |
Posizioni attive di Michael Kenison
| Società | Posizione | Inizio |
|---|---|---|
| PROTO LABS, INC. | Corporate Officer/Principal | 01/06/2021 |
Precedenti posizioni note di Michael Kenison
| Società | Posizione | Fine |
|---|---|---|
Cardiac Science, Inc.
 Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PROTO LABS, INC. | Process Industries |
| Aziende private | 1 |
|---|---|
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Commercial Services |
- Borsa valori
- Insiders
- Michael Kenison
